These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 34390080)
1. Oral/oesophageal candidiasis is a risk factor for severe infection after kidney transplantation. Abe T; Futamura K; Goto N; Ohara K; Ogasa T; Tomosugi T; Okada M; Hiramitsu T; Narumi S; Watarai Y Nephrology (Carlton); 2022 Jan; 27(1):97-103. PubMed ID: 34390080 [TBL] [Abstract][Full Text] [Related]
2. Oral candidiasis in immunosuppressed children and young adults after liver or kidney transplantation. Olczak-Kowalczyk D; Pawłowska J; Garczewska B; Smirska E; Grenda R; Syczewska M; Kowalczyk W Pediatr Dent; 2010; 32(3):189-94. PubMed ID: 20557701 [TBL] [Abstract][Full Text] [Related]
3. Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients. Veroux M; Macarone M; Fiamingo P; Cappello D; Gagliano M; Di Mare M; Vizcarra D; Spataro M; Giuffrida G; Sorbello M; Severino V; Veroux P Transplant Proc; 2006 May; 38(4):1037-9. PubMed ID: 16757256 [TBL] [Abstract][Full Text] [Related]
4. [Orointestinal candidiasis with special emphasis on esophageal candidiasis]. Bernhardt J Mycoses; 1999; 42 Suppl 1():68-72. PubMed ID: 10592720 [TBL] [Abstract][Full Text] [Related]
9. Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France. Albano L; Bretagne S; Mamzer-Bruneel MF; Kacso I; Desnos-Ollivier M; Guerrini P; Le Luong T; Cassuto E; Dromer F; Lortholary O; Clin Infect Dis; 2009 Jan; 48(2):194-202. PubMed ID: 19090753 [TBL] [Abstract][Full Text] [Related]
11. Oral candidiasis is a significant predictor of subsequent severe infections during immunosuppressive therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis. Yamaguchi M; Katsuno T; Iwagaitsu S; Nobata H; Kinashi H; Banno S; Ito Y BMC Infect Dis; 2019 Jul; 19(1):664. PubMed ID: 31349802 [TBL] [Abstract][Full Text] [Related]
12. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation. Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683 [TBL] [Abstract][Full Text] [Related]
13. The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon. Ambe NF; Longdoh NA; Tebid P; Bobga TP; Nkfusai CN; Ngwa SB; Nsai FS; Cumber SN Pan Afr Med J; 2020; 36():23. PubMed ID: 32774600 [TBL] [Abstract][Full Text] [Related]
14. [Successful treatment of oro-pharyngo-oesophageal Candida albicans infection after renal transplantation (author's transl)]. Zazgornik J; Kaiser R; Kopsa H; Schmidt P; Pötzi ; Hruby K Mykosen; 1978 Feb; 21(2):33-8. PubMed ID: 345119 [No Abstract] [Full Text] [Related]
16. Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney Transplant Recipients: Results From a Cohort in Germany. Schrezenmeier E; Budde K; Staeck O; Lehner L; Duerr M; Khadzhynov D; Dörner T; Halleck F Transplant Proc; 2017 Dec; 49(10):2269-2273. PubMed ID: 29198659 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of oral candidiasis in chronic renal failure and renal transplant pediatric patients. Olivas-Escárcega V; Rui-Rodríguez Mdel S; Fonseca-Leal Mdel P; Santos-Díaz MA; Gordillo-Moscoso A; Nernández-Sierra JF; de J Pozos-Guillén A J Clin Pediatr Dent; 2008; 32(4):313-7. PubMed ID: 18767464 [TBL] [Abstract][Full Text] [Related]
18. The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation. Lee J; Lee JG; Kim S; Song SH; Kim BS; Kim HO; Kim MS; Kim SI; Kim YS; Huh KH Nephrol Dial Transplant; 2016 Jun; 31(6):1013-21. PubMed ID: 27190360 [TBL] [Abstract][Full Text] [Related]